The stock of DexCom, Inc. (NASDAQ:DXCM) is a huge mover today! About 665,337 shares traded hands. DexCom, Inc. (NASDAQ:DXCM) has risen 4.43% since April 13, 2016 and is uptrending. It has outperformed by 0.51% the S&P500.
The move comes after 8 months positive chart setup for the $6.47B company. It was reported on Nov, 15 by Barchart.com. We have $89.90 PT which if reached, will make NASDAQ:DXCM worth $1.55 billion more.
DexCom, Inc. (NASDAQ:DXCM) Ratings Coverage
Out of 12 analysts covering Dexcom (NASDAQ:DXCM), 11 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 92% are positive. Dexcom has been the topic of 18 analyst reports since August 6, 2015 according to StockzIntelligence Inc. The rating was initiated by Morgan Stanley with “Overweight” on Monday, November 2. As per Monday, October 31, the company rating was upgraded by BTIG Research. As per Wednesday, February 24, the company rating was maintained by JP Morgan. On Friday, August 7 the stock rating was maintained by Piper Jaffray with “Buy”. The stock of DexCom, Inc. (NASDAQ:DXCM) has “Outperform” rating given on Thursday, October 15 by Leerink Swann. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Buy” rating by Desjardins Securities on Friday, September 16. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Buy” rating by Deutsche Bank on Friday, July 15. Sterne Agee CRT upgraded the shares of DXCM in a report on Thursday, October 15 to “Buy” rating. Canaccord Genuity maintained it with “Buy” rating and $70 target price in Wednesday, November 2 report. The company was maintained on Wednesday, February 24 by Benchmark.
According to Zacks Investment Research, “Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.”
Insitutional Activity: The institutional sentiment increased to 1.35 in Q2 2016. Its up 0.40, from 0.95 in 2016Q1. The ratio improved, as 30 funds sold all DexCom, Inc. shares owned while 77 reduced positions. 46 funds bought stakes while 98 increased positions. They now own 82.43 million shares or 5.55% more from 78.09 million shares in 2016Q1.
Td Asset Mngmt has 0% invested in the company for 18,000 shares. Bbva Compass Bank & Trust reported 3,704 shares or 0.02% of all its holdings. Janus Capital Mgmt Lc has 1.73M shares for 0.12% of their US portfolio. Moreover, Rockefeller Services Incorporated has 0% invested in DexCom, Inc. (NASDAQ:DXCM) for 1,902 shares. Arrowpoint Asset Mgmt Ltd Liability has 432,736 shares for 0.7% of their US portfolio. Next Century Growth Invsts Ltd Liability Corp reported 47,719 shares or 0.18% of all its holdings. Fifth Third Bank & Trust owns 136 shares or 0% of their US portfolio. Polar Cap Llp reported 15,163 shares or 0.02% of all its holdings. Susquehanna Ltd Liability Partnership has 8,632 shares for 0% of their US portfolio. Bank & Trust Of Mellon holds 0.01% of its portfolio in DexCom, Inc. (NASDAQ:DXCM) for 422,400 shares. Parkside Fincl Financial Bank, a Missouri-based fund reported 212 shares. Moreover, Federated Investors Inc Pa has 0.6% invested in DexCom, Inc. (NASDAQ:DXCM) for 2.60 million shares. Legal And General Gp Public Lc owns 5,412 shares or 0% of their US portfolio. Ftb has 3,780 shares for 0.04% of their US portfolio. Diversified Trust accumulated 0.12% or 13,488 shares.
Insider Transactions: Since May 18, 2016, the stock had 0 insider purchases, and 62 selling transactions for $55.88 million net activity. 7,000 shares were sold by SAYER KEVIN R, worth $559,457 on Wednesday, July 13. On Tuesday, August 9 the insider LISTER JOHN sold $324,217. The insider Balo Andrew K sold $464,366. ROPER JESS had sold 2,470 shares worth $232,155. MOY JEFFREY sold 6,866 shares worth $487,486. 20,000 shares were sold by VALDES JORGE A, worth $1.23M. On Monday, May 23 DOUBLEDAY RICHARD sold $106,446 worth of the stock or 1,674 shares.
More recent DexCom, Inc. (NASDAQ:DXCM) news were published by: Fool.com which released: “Here’s Why DexCom, Inc. Is Plunging Today” on November 02, 2016. Also Globenewswire.com published the news titled: “DexCom, Inc. (Nasdaq: DXCM) to Ring The Nasdaq Stock Market Opening Bell” on November 11, 2016. Prnewswire.com‘s news article titled: “Actor Derek Theler and Dexcom Take Center Stage to Raise Awareness of Diabetes” with publication date: October 20, 2016 was also an interesting one.
DXCM Company Profile
Dexcom, Inc. (Dexcom), incorporated on May 13, 1999, is a medical device company. The Firm is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. The Company’s products consist of SEVEN PLUS, DexCom G4, DexCom G4 PLATINUM, DexCom Share System and DexCom G5 Mobile. The Firm had received Conformite Europeene Marking (CE Mark) approval for its fourth generation continuous glucose monitoring system, the DexCom G4 system, enabling commercialization of the DexCom G4 system in the European Union, Australia, New Zealand and the countries in Asia and Latin America.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.